A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 and Humalog Across Different Subcutaneous Doses in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2018
At a glance
- Drugs Insulin lispro (Primary)
- Indications Diabetes mellitus; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 23 Jun 2018 According to an Eli Lilly media release, data from three phase Ib studies, including this trial will be presented at the 78th Scientific Session of the American Diabetes Association (ADA).
- 19 Feb 2018 Status changed from active, no longer recruiting to completed.
- 21 Dec 2017 Status changed from recruiting to active, no longer recruiting.